MIT Alliance for Research and Technology, Singapore
Kimberley Tam graduated from The University of Adelaide 2010, PhD in Medicine (Obstetrics and Gynaecology). He had completed his postdoctoral career with Cancer Science Institute of Singapore till 2014 developing Patient-derived xenografts for drug testing. He had served in the Department of Obstetrics and Gynaecology at National University of Singapore investigating the effects of Human Wharton’s Jelly Stem Cells and wound healing till 2016 and is currently based at Singapore-MIT Alliance of Research and Technology establishing pre-clinical evaluations and critical quality attributes (cQAs) for stem cell manufacturing and precision medicine. Kimberley Tam’s Research and Interests include – Developing various animal models for pre-clinical evaluation, bringing bench to bedside therapies and also developing in-vitro diagnostic platform for stem cell cQAs.